Investor Presentation Torrent Pharmaceuticals Ltd - 500420 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Investor Presentation
Investor Presentation Torrent Pharmaceuticals Ltd - 500420 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Investor Presentation
Investor Presentation TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Investor Presentation on Financial Results Q3 FY 2024-25.
Investor Presentation TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Investor Presentation on Financial Results Q2 FY 2024-25.
Investor Presentation TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Investor Presentation.
Investor Presentation TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Investor presentation
Investor Presentation TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Investor presentation
Investor Presentation TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Investor presentation
Investor Presentation TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Presentation to analyst on unaudited consolidated financial result for quarter ended 30.06.2023
Investor Presentation TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Presentation to analysts on Audited Financial Results for the quarter and year ended 31st March, 2023